Events

Recall of VerifyNow IIb/IIIa 25 Test and VerifyNow IIb/IIIa 10 Test (An in vitro Diagnostic Medical Device (IVD))

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Inverness Medical Innovations Australia Pty Ltd T/A Alere.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    RC-2014-RN-00273-1
  • Event Risk Class
    Class II
  • Event Initiated Date
    2014-03-03
  • Event Country
    Australia
  • Event Source
    DHTGA
  • Event Source URL
    https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2014-RN-00273-1
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    The manufacturer, accumetrics, has determined that the referenced lot of these products may result in the reporting of an erroneous low platelet aggregation unit (pau) result. lower than actual or expected pau values may contribute to excess administration of iib/iiia antiplatelet agents.
  • Action
    Alere is advising their customers to discontinue use of the affected lots and dispose of any remaining tests. Replacement kits will be provided. Review of past results should be undertaken at the discretion of the Laboratory Medical Director or attending physician.

Device

VerifyNow IIb/IIIa 25 Test and VerifyNow IIb/IIIa 10 Test (An in vitro Diagnostic Medical Device ...
  • Model / Serial
    VerifyNow IIb/IIIa 25 Test and VerifyNow IIb/IIIa 10 Test (An in vitro Diagnostic Medical Device (IVD))VerifyNow IIb/IIIa 25 Test Catalogue No. AC85011 Lot: WC0180C Lot Expiry: 21/10/2013VerifyNow IIb/IIIa 10 Test Catalogue No. AC85310 Lot: WC0182D Lot Expiry: 8/7/2014
  • Manufacturer
    Inverness Medical Innovations Australia Pty Ltd T/A Alere

Manufacturer

Inverness Medical Innovations Australia Pty Ltd T/A Alere
  • Manufacturer Parent Company (2017)
    Abbott Laboratories
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    DHTGA